Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Bihar, India, is the source of nearly one-half of the world's burden of visceral leishmaniasis and, unfortunately, drug resistance has ended the usefulness of pentavalent antimony (Sb) therapy.

New Treatment Approach for Indian Visceral Leishmaniasis